NCM
Nantahala Capital Management Portfolio holdings
AUM
$1.41B
This Quarter Return
+2.28%
1 Year Return
+32.9%
3 Year Return
+104.34%
5 Year Return
+145.08%
10 Year Return
+443.66%
AUM
$1.02B
AUM Growth
+$1.02B
(-12%)
Cap. Flow
-$141M
Cap. Flow
% of AUM
-13.8%
Top 10 Holdings %
Top 10 Hldgs %
46.08%
Holding
129
New
15
Increased
17
Reduced
59
Closed
17
Top Buys
| 1 |
Pathward Financial
CASH
|
$11.3M |
| 2 |
iShares Russell 2000 ETF
IWM
|
$8.49M |
| 3 |
Costco
COST
|
$7.15M |
| 4 |
Ventyx Biosciences
VTYX
|
$4.07M |
| 5 |
IDEAYA Biosciences
IDYA
|
$3.78M |
Top Sells
| 1 |
Syndax Pharmaceuticals
SNDX
|
$30.9M |
| 2 |
Avalo Therapeutics
AVTX
|
$20.5M |
| 3 |
Light & Wonder
LNW
|
$17.8M |
| 4 |
Soleno Therapeutics
SLNO
|
$14.8M |
| 5 |
Semler Scientific
SMLR
|
$10.3M |
Sector Composition
| 1 | Healthcare | 43.43% |
| 2 | Consumer Discretionary | 19.31% |
| 3 | Industrials | 9.47% |
| 4 | Communication Services | 6.18% |
| 5 | Financials | 6.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Cidara Therapeutics
CDTX
$1.66B
| $2.92M | 0.19% | 4,559,201 -259,889 | -5% | -$167K |
|
|
ARYD
52
DELISTED
ARYA Sciences Acquisition Corp IV Class A Odinary Shares
ARYD
| $2.83M | 0.18% | 285,730 -37,199 | -12% | -$369K |
|
|
53
Semler Scientific
SMLR
$439M
| $2.72M | 0.18% | 72,397 -274,209 | -79% | -$10.3M |
|
|
IMTXW
54
DELISTED
Immatics N.V. Warrants
IMTXW
| $2.68M | 0.17% | 987,432 -48,181 | -5% | -$131K |
|
55
Bioventus
BVS
$495M
| $2.65M | 0.17% | +378,839 | New | +$2.65M |
|
56
Curis
CRIS
$20.9M
| $2.43M | 0.16% | 3,420,510 -207,652 | -6% | -$148K |
|
|
TCDA
57
DELISTED
Tricida, Inc. Common Stock
TCDA
| $2.41M | 0.16% | +229,610 | New | +$2.41M |
|
58
Scully Royalty
SRL
$78.3M
| $2.36M | 0.15% | 318,493 -452,703 | -59% | -$3.35M |
|
59
Payoneer
PAYO
$2.5B
| $2.33M | 0.15% | 385,366 | – | – |
|
60
Rezolute
RZLT
$619M
| $1.97M | 0.13% | +718,736 | New | +$1.97M |
|
|
AAN
61
DELISTED
The Aaron's Company, Inc.
AAN
| $1.96M | 0.13% | +201,467 | New | +$1.96M |
|
62
Spyre Therapeutics
SYRE
$996M
| $1.95M | 0.13% | 3,710,778 -166,533 | -4% | -$87.6K |
|
|
63
Avalo Therapeutics
AVTX
$122M
| $1.82M | 0.12% | 547,814 -6,162,513 | -92% | -$20.5M |
|
64
Neuropace
NPCE
$303M
| $1.66M | 0.11% | 443,502 -34,936 | -7% | -$131K |
|
|
MACK
65
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
| $1.61M | 0.1% | 429,596 -61,913 | -13% | -$232K |
|
|
IDW
66
DELISTED
IDW Media Holdings
IDW
| $1.6M | 0.1% | 1,039,830 -13,022 | -1% | -$20.1K |
|
|
PNT
67
DELISTED
POINT Biopharma Global Inc. Common Stock
PNT
| $1.53M | 0.1% | +197,783 | New | +$1.53M |
|
68
Anebulo Pharmaceuticals
ANEB
$103M
| $1.43M | 0.09% | +511,073 | New | +$1.43M |
|
69
Nautilus Biotechnolgy
NAUT
$85.9M
| $1.39M | 0.09% | 655,338 -129,460 | -16% | -$274K |
|
70
Gyre Therapeutics
GYRE
$703M
| $1.29M | 0.08% | 2,554,735 -201,168 | -7% | -$101K |
|
71
Neuronetics
STIM
$220M
| $1.21M | 0.08% | 380,325 -387,075 | -50% | -$1.23M |
|
|
AGS
72
DELISTED
PlayAGS
AGS
| $1.18M | 0.08% | +222,518 | New | +$1.18M |
|
|
73
Soleno Therapeutics
SLNO
$3.6B
| $1.01M | 0.07% | 604,179 -8,832,333 | -94% | -$14.8M |
|
74
Elicio Therapeutics
ELTX
$172M
| $981K | 0.06% | 1,066,012 -64,989 | -6% | -$59.8K |
|
|
ACER
75
DELISTED
Acer Therapeutics Inc. Common Stock (DE)
ACER
| $968K | 0.06% | 696,538 -44,472 | -6% | -$61.8K |
|